fda tirzepatide compounding warning 2024 2025 🚨 Moves to Permanently Shut Down Compounded GLP-1s The FDA is taking steps to eliminate large-scale of GLP-1 medications like semaglutide and tirzepatide, signaling a major shift in how these February 17, 2026: Pennsylvania compounding

If fatigue persists beyond 6 weeks, discussing alternative dosing strategies with your provider helps identify whether the tiredness relates to semaglutide or another factor

Provider supervision is essential to distinguish medication effects from underlying conditions and ensure safe dose escalation

This weekly injection slows digestion, reduces appetite, and improves blood sugar control

That number sounds aggressive until you consider that lean mass loss is the single biggest risk of rapid weight loss, and protein is the primary dietary lever against it

Meta-analyses show that semaglutide increases the likelihood of discontinuing treatment (relative risk 1.67, 95% CI 1.27-2.21), primarily due to gastrointestinal adverse events

Their recognized neuroprotection in PD models is thought to arise from their promotion of survival of dopaminergic neurons in the SN